INS and type 2 diabetes mellitus: Therefore, the present study was designed to directly compare the PD properties of increasing doses insulin detemir and insulin glargine in severely obese (WHO grade 2 or higher) patients with type 2 diabetes over a 30 hour period in a randomised cross-over design.